Foundation for Global Skin Health Strategies

Co-Founders

Board
of Directors

Scientific
Advisory Board

Business
Advisory Board

Foundation Board members meeting at Harvard Club in New York.

John G. Callahan (left) and William M. Noé attend presentation on advances in the treatment of Melanoma.

Related
Resources

  • Alaur Skin Solutions
  • American Academy
    of Dermatology
  • American Contact Dermatitis Society
  • The American Society for Clinical Investigation
  • Auriga International
  • Biopelle
  • Ferndale Laboratories Inc.
  • Dr. Albert Lefkovits
  • Dr. William Levis
  • University of Maryland School of Medicine

Scientific Advisory Board

Anthony Gaspari, M.D.

Anthony Gaspari, M.D., a Dermatologist with a special interest and expertise in immunology and skin allergies, is the chairman of the Department of Dermatology at the University of Maryland School of Medicine and chief of dermatology at the University of Maryland Medical Center. He is past President of the American Contact Dermatitis Society.

He is the Shapiro Professor of Dermatology and also a professor of microbiology and immunology at the University of Maryland, School of Medicine. He is the director of the cutaneous immunopathology laboratory at the University of Maryland Medical Center, which studies and diagnoses complex skin disorders through cellular analysis.

"He is not only an outstanding clinician, but also a talented researcher whose work is advancing our understanding of the skin’s role in the human immune system," says Donald E. Wilson, M.D., M.A.C.P., Vice President for Medical Affairs, University of Maryland, and Dean of the School of Medicine.

Dr. Gaspari says that he hopes to build on the department’s strengths, particularly in treating skin cancer and allergies, and to develop a clinical and basic science research program that will translate into better therapies for patients. "We’ve always had a strong clinical program, and I would like to recruit more doctors who are interested in doing research as well as treating patients. I also am very committed to education and using the latest technologies to teach the next generation of dermatologists," he says.

Dr. Gaspari has done considerable research in cutaneous immunology and recently was awarded $1.2 million from the National Institutes of Health (NIH) to study skin allergies. He also has a $524,000 grant from the U.S. Veterans Health Administration to investigate allergic reactions to natural rubber latex.

A graduate of Temple University and Jefferson Medical College, Dr. Gaspari completed his residency at the Emory School of Medicine and a fellowship in cutaneous immunology at the NIH.

He spent 11 years at the University of Rochester in Rochester, N.Y., serving as an associate professor of dermatology and associate professor of oncology at the School of Medicine and Dentistry. He was acting chairman of the Department of Dermatology in 1996. Dr. Gaspari was also on the staff of Strong Memorial Hospital and Monroe Community Hospital in Rochester, N.Y., from 1990 to 2001 and was director of the clinical skin immunopathology service at Strong Memorial Hospital from 1990 to 1995.

He has published more than 100 peer-reviewed manuscripts, book chapters and review articles. He serves on the editorial boards of several journals as well as NIH grant review panels and U.S. Food and Drug Administration advisory board committees. Dr. Gaspari is also the outgoing president of the American Contact Dermatitis Society and serves on the organization’s executive committee. He is a member of the American Association of Immunologists, the Clinical Immunology Society, the American Academy of Dermatology and the Dermatology Foundation.

Albert Lefkovits, M.D.

Albert Lefkovits, M.D., a Dermatologist specializing in Surgical, Medical and Cosmetic Dermatology. He is Member of the American Academy of Dermatology; Co-Director, Cosmetic Dermatologic Surgery Training Program, at Mount Sinai Hospital; Associate Clinical Professor of Dermatology, Mount Sinai School of Medicine; Fellow, Royal Society of Medicine; Member of the Medical Advisory Council of the Skin Cancer Foundation.

In addition, Albert Lefkovits is Associate Clinical Professor of Dermatology at the Mount Sinai School of Medicine and is a prominent member of the Mount Sinai Medical Center, having served as President of the Mount Sinai Alumni from 1995-1997. He is also past president of the Dermatology Society of Greater New York.

Dr. Lefkovits has published over thirty scientific articles in major peer-reviewed publications such as The New England Journal of Medicine, The Lancet, Cutis and the Archives of Dermatology with subjects ranging from the diagnosis and treatment of malignant melanoma to psoriasis. He is co-author of an original paper documenting the criteria for immunofluorescent diagnosis of pemphigus, bullous pemphigoid and dermatitis herpetiformis, proving the autoimmune nature of these diseases.

He chairs the Annual Mount Sinai Mid-Winter Symposium entitled Advances in Cosmetic, Medical and Surgical Dermatology. At this time, Dr. Lefkovits is on the Medical Advisory Board of Dermatology Insights and Healthy Aging Magazine, and is a member of the Committee on Physician Practice of the American Academy of Dermatology. He is also a member of the Communications Council of the American Academy of Dermatology.

Treating patients from all over the world in his dermatology practice in New York, he is director of the Park Avenue Center for Advanced Medical and Cosmetic Dermatology. His biography is listed in Who’s Who in America, Who’s Who in the World, Who’s Who in Medicine and Healthcare and Who’s Who in Science and Engineering.

Michael Mardiney, Jr., MD, PhD

This specialist Physician has broad background, expertise and interest in Immunology and Immunomolecular Pathology as applied to the pathogenesis, control and treatment of Human Disease. Particular interest at this time is devoted to methods of reconstitution and redirecting optimum function of the human immune system in those situations where degradation or aberrant activity occurs. The study and treatment of dysfunction of IgE associated with mast cell dysfunction as manifested by atopic disease in man is actively underway. Restoration of more optimum immune function in the face of a decaying immune system as noted in aging is being actively pursued.

Doctor Mardiney’s hospital affiliations include: The Good Samaritan Hospital, Harbor Hospital, York Hospital. He is a Diplomate of the American Board of Allergy and Immunology and Conjoint Board of the American Board of Internal Medicine and the American Board of Pediatrics. His memberships in professional societies are numerous, including: American College of Allergy and Immunology, Clinical Immunology Society and the Association of Medical Laboratory Immunologists.

Adnan Nasar, M.D., PhD

Adnan Nasir, M.D., PhD, is clinical assistant professor of dermatology at UNC Chapel Hill. He has interests in molecular immunodermatology and nanotechnology. He maintains an active clinical practice, teaches students and residents and conducts clinical trials in inflammatory skin diseases. He supervises basic science research in nanotechnology, including the use of nanocantilevers for the diagnosis of skin disease, microneedles for transdermal drug delivery, and nanoceramics for cutaneous applications.

Stephen Prystowsky, M.D.

At home in Chapel Hill, NC, Dr. Prystowsky graduated from John’s Hopkins Medical School where he also completed his residency in 1975. He went on from there to serve as a Major and Research Dermatologist in the Military Medical Corps at the Letterman Army Institute of Research in San Francisco and then proceeded into private practice in Dermatology in Danville, California. Dr. Prystowsky was Assistant Clinical Professor of Dermatology at the University of California, San Francisco for over 20 years starting in the late 1970’s and also held the position of Assistant Clinical Professor of Medicine, University of California, Davis from 1980 to 1986. He was Assistant Clinical Professor of Dermatology, New York University from 2004 to 2008 and is currently Associate Clinical Professor of Dermatology there.

Dr. Prystowsky has published extensively on a wide variety of dermatology related and other subjects. He is a diplomat of the American Board of Dermatology and the National Board of Medical Examiners. He was honored with the Part-Time Attending of the Year Award at Bellevue Hospital, NYU in 2007 and received the Resident Advocate of the Year Award at NYU in the following year.

Animesh A. Sinha, MD, PhD

Animesh A. Sinha, MD, PhD joined the Michigan State University College of Human Medicine as Chief, N.V. Perricone Division of Dermatology and Cutaneous Sciences and Director, Center for Investigative Dermatology in October 2005. Following the completion of his M.D. degree in 1982 from the University of Alberta, Dr. Sinha received his Ph.D. degree (Medical Sciences - Immunology) in 1986 from the same institution. Subsequently, he pursued post-doctoral research at Stanford University in the Department of Microbiology and Immunology. Dr. Sinha's subspecialty training in dermatology was completed at Yale University/Yale-New Haven Hospital. Prior to his appointment at MSU-CHM, Dr. Sinha was Associate Professor and Program Director, Department of Dermatology, Weill Medical College of Cornell University, where he joined the faculty in 1998. Dr. Sinha is a board-certified dermatologist whose professional goals aim to bridge the bench to the bedside. He has published extensively, including four peer-reviewed articles in the journal Science. He received numerous honors and awards for his academic activities. He continues to be sought after as an invited speaker worldwide on a broad range of clinical and research topics.

His long-term research interests are in the field of autoimmunity, particularly the genetic and immunogenetic basis of skin disease. Specific projects include the detailed study of HLA class II-peptide-T cell interactions to understand the induction and regulation of disease. Dr. Sinha's group is also using cutting edge microarray technology for the purpose of genetic, genomic and proteomic analyses across several autoimmune skin diseases including psoriasis, pemphigus vulgaris, alopecia areata, vitiligo, and cutaneous lupus to yield a broader understanding of basic skin biology and underlying disease mechanisms. The overall aim of Dr. Sinha's work is to apply detailed molecular and systems biology based strategies toward the development of novel approaches to the diagnosis, study of pathogenesis and therapy of skin disease